Search results
Board of Infibeam Avenues approves transfer of its AI biz to new wholly owned subsidiary
Business Standard India· 1 day agoAt meeting held on 09 July 2024The Board of Infibeam Avenues at its meeting held on 09 July 2024 has...
Artists stand up for their rights against AI threats
Creative Bloq· 4 days agoShe plans to take down many of her posts, and put her efforts into her website, newsletter and Patreon. “[I’ll use Instagram] just to give teasers and...
One year and 175 million users later, Threads is still not a Twitter ‘killer’
CNBC Awaaz· 5 days agoChaos was reigning supreme at Elon Musk’s X — or was it called Twitter then? Mark Zuckerberg knows...
Nothing launches CMF Phone 1 with modular design and functional accessories
Indian Express· 2 days agoOn Monday, Nothing’s sub-brand CMF launched its first smartphone––the CMF Phone 1––with a starting...
UPSC Essentials | Mains answer practice — GS 3 : Questions on National Security Advisor and...
Indian Express· 1 day agoIn light of recent agricultural reforms and farmer protests, analyse the significance of bridging...
Tech wrap Jul 4: Motorola Razr 50 Ultra, CMF Phone 1, OnePlus Summer launch
Business Standard India· 6 days agoTech News Today: Motorola launched Razr 50 Ultra flip-style foldable in India. Nothing shows CMF...
Hard checks are now less likely to damage your credit score: Adhil Shetty
The Telegraph· 2 days agoCredit score checks were primarily seen in two forms: hard and soft. A soft check is when you check...
Gen AI-powered creativity: How CMOs are unleashing new revenue streams
Financial Express· 2 days agoFrom personalized campaigns tailored to individual preferences to automated content creation,...
Rida-hailing platform Ola introduces Ola Maps
YourStory· 2 days agoAccording to a blog post, Ola Maps aims to tackle these with AI-powered India-specific algorithms, real-time data from millions of vehicles, and by...
Pipeline Moves: Alnylam’s Amvuttra approval prospects up after Phase III win
Clinical Trials Arena· 2 days agoThe LoA for Amvuttra shot up by 11 percentage points from 55% to 66% in familial amyloid...